AI assistant
Sending…
NEOGENOMICS INC — Director's Dealing 2019
Jun 11, 2019
32227_dirs_2019-06-10_5478bbf8-5951-490d-bfdd-118942372611.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2019-06-06
Reporting Person: KANOVSKY STEPHEN M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-06-06 | Common Stock | A | 3419 | — | Acquired | 3419 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-06 | Stock Options (Right to Buy) | $22.52 | A | 4269 | Acquired | 2026-06-06 | Common Stock (4269.0) | Direct |
More from NEOGENOMICS INC
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24